Literature DB >> 34077977

Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients.

Ludwig Traby1, Marietta Kollars1, Manuel Kussmann1, Matthias Karer1, Hana Šinkovec2, Elisabeth Lobmeyr1, Alexander Hermann1, Thomas Staudinger1, Peter Schellongowski1, Bernhard Rössler3, Heinz Burgmann1, Paul A Kyrle1, Sabine Eichinger1.   

Abstract

OBJECTIVES: Pulmonary thrombus formation is a hallmark of coronavirus disease 2019 (COVID-19). A dysregulated immune response culminating in thromboinflammation has been described, but the pathomechanisms remain unclear.
METHODS: We studied 41 adult COVID-19 patients with positive results on reverse-transcriptase polymerase-chain-reaction assays and 37 sex- and age-matched healthy controls. Number and surface characteristics of extracellular vesicles (EVs) and citrullinated histone H3 levels were determined in plasma upon inclusion by flow cytometry and immunoassay.
RESULTS: In total, 20 patients had severe and 21 nonsevere disease. The number of EV (median [25th, 75th percentile]) was significantly higher in patients compared with controls (658.8 [353.2, 876.6] vs. 435.5 [332.5, 585.3], geometric mean ratio [95% confidence intervals]: 2.6 [1.9, 3.6]; p < 0.001). Patients exhibited significantly higher numbers of EVs derived from platelets, endothelial cells, leukocytes, or neutrophils than controls. EVs from alveolar-macrophages and alveolar-epithelial cells were detectable in plasma and were significantly higher in patients. Intercellular adhesion molecule-1-positive EV levels were higher in patients, while no difference between tissue factor-positive and angiotensin-converting enzyme-positive EV was seen between both groups. Levels of EV did not differ between patients with severe and nonsevere COVID-19. Citrullinated histone H3 levels (ng/mL, median [25th, 75th percentile]) were higher in patients than in controls (1.42 [0.6, 3.4] vs. 0.31 [0.1, 0.6], geometric mean ratio: 4.44 [2.6, 7.7]; p < 0.001), and were significantly lower in patients with nonsevere disease compared with those with severe disease.
CONCLUSION: EV and citrullinated histone H3 are associated with COVID-19 and could provide information regarding pathophysiology of the disease. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34077977     DOI: 10.1055/a-1522-4131

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   6.681


  10 in total

1.  Worse Disease Prognosis Is Associated to an Increase of Platelet-Derived Extracellular Vesicles in Hospitalized SARS-CoV-2 Patients.

Authors:  Davide Raineri; Chiara Venegoni; Maria Grazia Calella; Rosanna Vaschetto; Lorenza Scotti; Elena Canciani; Marcello Manfredi; Francesco Gavelli; Luigi Castello; Annalisa Chiocchetti; Giuseppe Cappellano
Journal:  Dis Markers       Date:  2022-07-07       Impact factor: 3.464

Review 2.  Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis.

Authors:  Marie Ebeyer-Masotta; Tanja Eichhorn; René Weiss; Lucia Lauková; Viktoria Weber
Journal:  Front Cell Dev Biol       Date:  2022-07-06

Review 3.  Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview.

Authors:  Igor Kudryavtsev; Artem Rubinstein; Alexey Golovkin; Olga Kalinina; Kirill Vasilyev; Larisa Rudenko; Irina Isakova-Sivak
Journal:  Viruses       Date:  2022-05-18       Impact factor: 5.818

Review 4.  Platelet and extracellular vesicles in COVID-19 infection and its vaccines.

Authors:  Hadi Goubran; Jerard Seghatchian; Waleed Sabry; Gaafar Ragab; Thierry Burnouf
Journal:  Transfus Apher Sci       Date:  2022-05-21       Impact factor: 2.596

5.  Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.

Authors:  Marie Ebeyer-Masotta; Tanja Eichhorn; René Weiss; Vladislav Semak; Lucia Lauková; Michael B Fischer; Viktoria Weber
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

6.  Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients.

Authors:  Polina Len; Gaukhar Iskakova; Zarina Sautbayeva; Aigul Kussanova; Ainur T Tauekelova; Madina M Sugralimova; Anar S Dautbaeva; Meruert M Abdieva; Eugene D Ponomarev; Alexander Tikhonov; Makhabbat S Bekbossynova; Natasha S Barteneva
Journal:  Front Cardiovasc Med       Date:  2022-03-11

Review 7.  The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Authors:  Alicia S Eustes; Sanjana Dayal
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

8.  Increased Circulating CD62E+ Endothelial Extracellular Vesicles Predict Severity and in- Hospital Mortality of COVID-19 Patients.

Authors:  Fariza Mezine; Coralie L Guerin; Aurélien Philippe; Nicolas Gendron; Lou Soret; Olivier Sanchez; Tristan Mirault; Jean-Luc Diehl; Richard Chocron; Chantal M Boulanger; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2022-08-18       Impact factor: 6.692

Review 9.  A Defective Viral Particle Approach to COVID-19.

Authors:  Maria Kalamvoki; Vic Norris
Journal:  Cells       Date:  2022-01-17       Impact factor: 6.600

10.  Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19.

Authors:  Elena Campello; Claudia Maria Radu; Chiara Simion; Luca Spiezia; Cristiana Bulato; Sabrina Gavasso; Daniela Tormene; Nicola Perin; Giacomo Turatti; Paolo Simioni
Journal:  Front Cell Dev Biol       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.